ID

41386

Beskrivning

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01925755

Länk

https://clinicaltrials.gov/show/NCT01925755

Nyckelord

  1. 2019-01-19 2019-01-19 -
  2. 2020-09-28 2020-09-28 -
Rättsinnehavare

see on clinicaltrials.gov

Uppladdad den

28 september 2020

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Stroke Secondary to Atrial Fibrillation, NCT01925755

Eligibility Stroke Secondary to Atrial Fibrillation, NCT01925755

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female patients ≥ 18 years old who start treatment with rivaroxaban
Beskrivning

Age, Gender, Start of Rivaroxaban

Datatyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
UMLS CUI [3,1]
C1739768
UMLS CUI [3,2]
C0439659
non-valvular atrial fibrillation is documented in patients' file
Beskrivning

Non-valvular Atrial fibrillation

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0004238
UMLS CUI [1,2]
C0018826
UMLS CUI [1,3]
C1314939
UMLS CUI [1,4]
C0332197
prior tia/stroke history
Beskrivning

Tia/stroke history

Datatyp

boolean

Alias
UMLS CUI [1]
C0559159
UMLS CUI [2]
C0455536
if tia - more than 72 hours after documented tia
Beskrivning

Tia more than 72 hours ago

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C0007787
if stroke - more than 2 weeks after non-hemorrhagic stroke
Beskrivning

Non-hemorrhagic stroke more than 2 weeks ago

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0038454
UMLS CUI [1,2]
C0231290
written informed consent
Beskrivning

Informed Consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindications for use of xarelto® in accordance with approved product label
Beskrivning

Contraindications Xarelto®

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1739768
UMLS CUI [1,2]
C0522473
previous thromboprophylaxis treatment for stroke/tia prevention
Beskrivning

Anticoagulant prophylaxis for stroke/tia prevention

Datatyp

boolean

Alias
UMLS CUI [1]
C0199242
UMLS CUI [2,1]
C0948008
UMLS CUI [2,2]
C0199176
UMLS CUI [3,1]
C0007787
UMLS CUI [3,2]
C0199176
any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
Beskrivning

Other reason affecting participation

Datatyp

boolean

Alias
UMLS CUI [1,1]
C3840932
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C2348568
UMLS CUI [1,4]
C0022423
UMLS CUI [1,5]
C0031831

Similar models

Eligibility Stroke Secondary to Atrial Fibrillation, NCT01925755

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Age, Gender, Start of Rivaroxaban
Item
male and female patients ≥ 18 years old who start treatment with rivaroxaban
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C1739768 (UMLS CUI [3,1])
C0439659 (UMLS CUI [3,2])
Non-valvular Atrial fibrillation
Item
non-valvular atrial fibrillation is documented in patients' file
boolean
C0004238 (UMLS CUI [1,1])
C0018826 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Tia/stroke history
Item
prior tia/stroke history
boolean
C0559159 (UMLS CUI [1])
C0455536 (UMLS CUI [2])
Tia more than 72 hours ago
Item
if tia - more than 72 hours after documented tia
boolean
C0231290 (UMLS CUI [1,1])
C0007787 (UMLS CUI [1,2])
Non-hemorrhagic stroke more than 2 weeks ago
Item
if stroke - more than 2 weeks after non-hemorrhagic stroke
boolean
C0038454 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Contraindications Xarelto®
Item
contraindications for use of xarelto® in accordance with approved product label
boolean
C1739768 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
Anticoagulant prophylaxis for stroke/tia prevention
Item
previous thromboprophylaxis treatment for stroke/tia prevention
boolean
C0199242 (UMLS CUI [1])
C0948008 (UMLS CUI [2,1])
C0199176 (UMLS CUI [2,2])
C0007787 (UMLS CUI [3,1])
C0199176 (UMLS CUI [3,2])
Other reason affecting participation
Item
any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
boolean
C3840932 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0022423 (UMLS CUI [1,4])
C0031831 (UMLS CUI [1,5])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial